✦ LIBER ✦

Therapeutic drug monitoring for everolimus in kidney transplantation using 12-month exposure, efficacy, and safety data

✍ Scribed by Marc I Lorber; Claudio Ponticelli; John Whelchel; Hartmut W Mayer; John Kovarik; Yulan Li; Heinz Schmidli

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

12-month safety and efficacy of everolim

✍ Helio Tedesco-Silva Jr; Stefan Vitko; Julio Pascual; Josette Eris; John C. Magee 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 504 KB

474: Assessing safety and efficacy of Ne

✍ H. Ross; J. Burton; P. Pflugfelder; M. Cantarovich; A. Ignaszewski; J. Howlett; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

55 Everolimus with Reduced CsA vs MMF wi

✍ H. Eisen; D. Pauly; R. Starling; H. Lehmkuhl; H. Ross; A. Kfoury; S. Wang; B. Ca 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 289 KB

Efficacy and safety of de novo or early

✍ Jacques Dantal; François Berthoux; Marie-Christine Moal; Lionel Rostaing; Christ 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 335 KB